Key facts
- It has raised $1.4M; the latest was Early Stage VC ($1.4M) in Feb 2026.
- Notable investors include Triwise Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Gulf Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Gulf Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gulf Biotechnology
Developer of marine derived bioactive materials and biopolymer based biomedical products intended to advance the industrialization of value marine bioactive materials. The company offers bio based materials, marine polysaccharide products, medical device related materials, disinfectant and cosmetic products, enabling cross sector applications through scientific research, material innovation and biotechnology commercialization.
- Sector
- Healthcare
- HQ
- Foshan, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Gulf Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gulf Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gulf Biotechnology in its N-PORT filings yet. We sweep new filings monthly.